Weekender: Cue, Google's COVID-19 test provider, raises $200M in IPO

Signup | Forward Weekender Oct.​ 2,​ 2021 | A roundup of this week's most read stories

Cue, Google's COVID-19 test provider, raises $200M in IPO The at-home test maker will use the money to scale up commercial and manufacturing infrastructure to support its portable diagnostic platform. Cue Health's Friday debut on the Nasdaq valued the company at $2.9 billion. Amid pandemic, medtech R&D, merger activity jumped: EY report Research and development spending at pure-play medtechs rose to a level last seen before the 2007-2008 financial crisis. FDA medical device regs, safety checks questioned by AMA ethics journal As it's typically safer to discontinue the use of a drug than an implant, it "might be reasonable" to hold some devices to higher standards, suggests Ariel Wampler, author and plastic and reconstructive surgery physician. Sponsored Content by Medtech Dive's studioID How digitalization can improve patient care The influx of new patient data from digitalization opens the doors to innovation in patient care. Discover how medtech companies are using data and analytics to enable value-added innovation in this webinar. FDA starts review after study finds Boston Scientific's Watchman is riskier in women The agency is working with manufacturers of LAAO devices, a market fought over by Boston Scientific and Abbott, to assess other sources of data before deciding on the next steps. CMS defends proposal to nix MCIT pathway, medtechs hold out hope If the bid to repeal the breakthrough payment rule is finalized, the agency's CMO committed to an alternative pathway that evaluates devices for Medicare patients potentially via clinical trials, outcome registries and real-world data. How Digitalization Can Improve Patient Care The influx of patient data from digitalization opens the doors to innovation in patient care. Discover how to use data and analytics to enable value-added innovation in this webinar. Learn More Best of What We're Reading STAT A new surgical robot is smaller, nimbler, and cheaper, its maker claims. But will it be better for patients? Kaiser Health News A Covid Test Costing More Than a Tesla? It Happened in Texas. TCTMD TAVI Is Broadening the Treatable AS Population, Not Cutting Into SAVR TechCrunch Activ Surgical raises $45 million Series B round to give surgeons eagle eyes Wall Street Journal In Well-Vaccinated Maine, Covid-19 Still Fills Hospitals With the Unvaccinated The New York Times How Accurate Are At-Home Covid Tests? Suggest a story we should read Upcoming Event Curating Data to Enable Patient Care Innovation Oct. 7, 2021 - Oct. 7, 2021 | Webinar 2pm ET Dive Into a Topic Medical Devices Policy & Regulation Clinical Trials Manufacturing Legal M&A Research Diagnostics Digital Health Imaging Share MedTech Dive: Daily Dive with others and get rewarded. You've referred 0 readers. To become an official Dive Insider, just successfully refer 10 contacts to MedTech Dive: Daily Dive. Here's your link to share: https://www.medtechdive.com/signup/insiders/?signup_referred_by=5f93078d7aa51972095c9316

More Than A Newsletter Related Publications BioPharma Dive | Healthcare Dive Connect With Us Twitter | LinkedIn Editorial Contact an editor | Meet the team Advertising Contact our team About MedTech Dive MedTech Dive provides in-depth journalism and insight into the most impactful news and trends shaping medical technology. The newsletters and website cover topics such as medical devices, diagnostics, digital health, regulation/compliance, R&D, M&A and more. Medtech Dive is a leading publication operated by Industry Dive. Our business journalists spark ideas and shape agendas for 10+ million decision makers in competitive industries. Sign up for the newsletter This email is optimized for display on mobile phones. MedTech Dive: Daily Dive is a product of Industry Dive, Inc. 1255​ 23rd Street NW, Suite 550, Washington,​ DC 20037. We value your privacy. We won't share your email address with anyone else without your permission. This message was sent to edwardlorilla1986.acciyo123@blogger.com. You can unsubscribe or switch to a weekly newsletter subscription anytime. See our full privacy policy.

Sign up | Manage subscription | Advertise with us | Submit story tip